Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: Features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences

European Radiology

Volumn 9, Issue 8, 1999, Pages 1535-1542

  Precetti Morel, S ^a   Bellin, M F ^a   Ghebontni, L ^a   Zaim S ^a   Opolon, P ^a   Poynard, T ^a   Mathurin, P ^a   Cluzel, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Contrast enhancement; Focal nodular hyperplasia; Liver; MR imaging; Neoplasm

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; LIVER; MALE; METHODOLOGY; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SUSPENSION;

ADULT; CONTRAST MEDIA; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; IRON; LIVER; MAGNETIC RESONANCE IMAGING; MALE; OXIDES; SUSPENSIONS;

EID: 0032613346     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050879     Document Type: Article

References (23)

1. Chambon C, Clément O, Le Blanche A, Schouman-Clayes E, Frija G (1993) Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 11: 509-519
2. Grangier C, Tourniaire J, Mentha G et al. (1994) Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr 18: 888-896
3. Bellin MF, Zaim S, Auberton E et al. (1994) Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 193: 657-663
4. Ros PR, Freeny PC, Harms SE et al. (1995) Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesion. Radiology 196: 481-488
5. Denys A, Arrivé L, Servois V et al. (1994) Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 193: 665-669
6. Duda SH, Laniado M, Kopp AF et al. (1994) Superparamagnetic iron oxide: detection of focal liver lesion at high-field-strength MR imaging. J Magn Reson Imaging 4: 309-314
7. Winter TC, Freeny PC, Nghiem HV et al. (1993) MR imaging with IV superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. AJR 161: 1191-1198
8. Vogl TJ, Hammerstingl R, Schwarz W et al. (1996) Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 198: 881-887
9. Grandin C, Van Beers B, Robert A, Gigot JF, Geubel A, Pringot J (1995) Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 19: 412-418
10. Buetow PC, Pantongrag-Brown L, Buck JL, Ros PR, Goodman ZD (1996) Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. Radio Graphics 16: 369-388
11. Vilgrain V, Fléjou JF, Arrivé L et al. (1992) Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. Radiology 184: 699-703
12. Mathieu D, Rahmouni A, Anglade MC et al. (1991) Focal nodular hyperplasia of the liver: assessment with contrast-enhanced turboFLASH MR imaging. Radiology 180: 25-30
13. Mattison GR, Glazer GM, Quint LE, Francis IR, Bree RL, Ensminger WD (1987) MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors. AJR 148: 711-715
14. Lee MJ, Saini S, Hamm B et al. (1991) Focal nodular hyperplasia of the liver: MR findings in 35 cases. AJR 156: 317-320
15. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ (1993) Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging. Radiology 186: 133-138
16. Yamamoto H, Yamashita Y, Yoshimatsu S, Baba Y, Takahashi M (1995) MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles. J Comput Assist Tomogr 19: 665-666
17. Hahn PF, Stark DD, Weissleder R, Elizondo G, Saini S, Ferruci JT (1990) Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumor. Radiology 174: 361-366
18. Schwartz LH, Seltzer SE, Tempany CMC et al. (1995) Superparamagnetic iron oxides hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences. J Magn Reson Imaging 5: 566-570
19. Majumdar S, Zoghbi SS, Gore JC (1989) The influence of pulse sequence on the relaxation effects of superparamagnetic iron oxide contrast agents. Magn Reson Med 10: 289-301
20. Rozenmam Y, Zou X, Kantor HL (1990) Signal loss induced by superparamagnetic iron oxide particles in NMR spin-echo images: the role of diffusion. Magn Reson Med 14: 31-39
21. Majumdar S, Zoghbi SS, Pope CF, Gore JC (1989) A quantitative study of relaxation rate enhancement produced by iron-oxide particles in polyacrylamide gels and tissue. Magn Reson Med 9: 185-202
22. Weissleder R, Papisov M (1992) Pharmaceutical iron oxides for MR imaging. Rev Magn Reson 4: 1-20
23. Grandin C, Van Beers B, Pauwels S, Demeure R, Jamart J, Pringot J (1997) Ferumoxides and Tc-99 m sulfur colloid: comparison of the tumor-to-liver uptake in focal nodular hyperplasia. J Magn Reson Imaging 7: 125-129